Sunday (27.10.2024)

08:00 – 09:30

Room: Großer Saal

Scientific Session Pediatric and Adolescent Treatment Concepts

  • Jonathan Friedberg
  • Christine Mauz-Körholz
  • 08:00–08:20

    Recent achievements and future goals in Pediatric and Young Adult HL: COG Perspective

    • Sharon Castellino
  • 08:20–08:40

    Recent achievements and future goals in Pediatric and Young Adult HL: EuroNET-PHL Perspective

    • Christine Mauz-Körholz
  • 08:40–09:00

    Appropriate endpoints for future trials in Pediatric and Young Adult HL, and opportunities for harmonization

    • Jamie Flerlage

  • Oral presentation of selected abstracts

10:00 – 11:30

Room: Großer Saal

Scientific Session Biology & Microenvironment

  • Sirpa Leppä
  • Margaret Shipp
  • 10:00–10:25

    Pathogenesis of HL

    • Ralf Küppers
  • 10:25–10:50

    Multimodal characterization of cHL

    • Christian Steidl

  • Oral presentation of selected abstracts

12:00 – 13:30

Room: Großer Saal

Satellite Symposium (by MSD) Satellite Symposium 2

  • Peter Borchmann
  • 12:00–12:30

    B-cell lymphoma pathology – illustrated for non- pathologists

    • Wolfram Klapper
  • 12:30–13:00

    Classical Hodgkin Lymphoma - Development of immune checkpoint inhibition beyond PD-1 blockade

    • Peter Borchmann
  • 13:00–13:30

    Diffuse Large B-cell Lymphoma - The current and future role of ADC in the context of immunotherapies

    • Sascha Dietrich

14:00 – 15:30

Room: Großer Saal

Scientific Session Older Patients

  • Paul J. Bröckelmann
  • Andrew Evens
  • 14:00–14:25

    Implementing Frailty Assessment for Treatment Guidance in HL

    • Sarah Rutherford
  • 14:25–14:50

    Optimal Use of Targeted Agents to Address Unmet Need in Older HL

    • Graham Collins

  • Oral presentation of selected abstracts

16:00 – 17:30

Room: Großer Saal

Satellite Symposium (by Takeda) Satellite Symposium 3

  • Peter Borchmann

18:00 – 19:30

Room: Großer Saal

Scientific Session Advanced Stages

  • Alex Herrera
  • Josée Zijlstra
  • 18:00–18:25

    Individualized treatment de-escalation improves overall outcomes

    • Peter Borchmann
  • 18:25–18:50

    Immune-chemotherapy overcomes the need for individualization

    • Jonathan Friedberg

  • Oral presentation of selected abstracts

ISHL13 Preliminary Program (PDF)

ISHL13 Preliminary Program (PDF)

Save the date

Save the event to your calendar

Archive

You can explore the ISHL12 program to get an impression of the broad spectrum and diversity of the congress.